08048036315
LANTUS SOLOSTAR 100 IU 3ML Supplier & Exporter from India to Australia - Adelaide South|Phoenix Exim


1. General Information

Lantus SoloStar 100 IU 3 mL contains insulin glargine, a long-acting form of insulin. It is a prescription medicine used to help control high blood glucose levels in adults and children with diabetes mellitus. Lantus provides a prolonged insulin effect and is generally administered once daily at the same time each day, according to the healthcare professional's prescription.

Lantus SoloStar is supplied as a 3 mL U-100 prefilled insulin pen, with 100 units of insulin glargine per mL. It is intended for subcutaneous injection and should be used according to the accompanying instructions and medical advice.

2. Product Information

  • Brand Name: Lantus SoloStar

  • Active Ingredient: Insulin Glargine

  • Strength: 100 Units/mL (U-100)

  • Pack Size: 3 mL prefilled pen

  • Dosage Form: Injectable solution

  • Medicine Type: Long-acting insulin

  • Route of Administration: Subcutaneous injection

  • Manufacturer/Brand: Sanofi

  • Prescription Status: Prescription medicine

The SoloStar pen is designed to allow the prescribed insulin dose to be dialed and administered subcutaneously. The solution should be clear and colorless and should not contain visible particles.

3. Uses of Lantus SoloStar

Lantus SoloStar is primarily used for:

  • Management of high blood glucose associated with diabetes mellitus

  • Providing long-acting basal insulin replacement

  • Helping maintain blood glucose control throughout the day and night

  • Supporting diabetes treatment alongside an appropriate diet, physical activity and other prescribed medicines

Lantus is not intended for the treatment of diabetic ketoacidosis.

4. Benefits of Lantus SoloStar

The potential benefits of insulin glargine therapy include:

  • Provides long-acting insulin coverage

  • Helps lower and control elevated blood glucose

  • Provides basal insulin support over an extended period

  • SoloStar provides a prefilled, ready-to-use pen format

  • Dose can be selected using the pen's dose dial

  • Once-daily administration may provide convenient basal insulin therapy when prescribed appropriately

Lantus is intended to be used as part of an overall diabetes-management plan under medical supervision.

5. Side Effects of Lantus SoloStar

Like other insulin medicines, Lantus may cause side effects. The most important potential adverse effect is hypoglycemia (low blood sugar), which can become serious or life-threatening.

Other possible side effects include:

  • Injection-site reactions

  • Swelling (edema)

  • Weight gain

  • Changes in fatty tissue at injection sites

  • Itching or rash

  • Allergic reactions

  • Low potassium levels

Severe allergic reactions may cause difficulty breathing, swelling of the face, tongue or throat, rapid heartbeat, dizziness or confusion and require immediate medical attention.

6. Common Side Effects

Some commonly reported effects associated with insulin glargine include:

  • Low blood sugar

  • Injection-site discomfort or reactions

  • Swelling

  • Weight gain

  • Skin or fatty-tissue changes at the injection site

  • Itching or rash

Symptoms of hypoglycemia can include shaking, sweating, rapid heartbeat, blurred vision, dizziness or confusion. Patients should discuss how to recognize and manage low blood sugar with their healthcare professional.

7. How to Use Lantus SoloStar

Use Lantus SoloStar only according to the dose and schedule prescribed by your doctor.

General administration guidance:

  1. Check the pen label and expiration date before use.

  2. Inspect the insulin; it should be clear and colorless with no visible particles.

  3. Attach a new compatible needle according to the pen instructions.

  4. Perform the required safety test.

  5. Select the prescribed dose using the dose selector.

  6. Inject the insulin under the skin as instructed by your healthcare professional.

  7. Appropriate injection areas include the abdomen, thighs and outer upper-arm fatty tissue.

  8. Rotate injection sites to help reduce the risk of skin thickening or other injection-site changes.

  9. Remove and safely discard the needle after use.

  10. Never share the pen or needles with another person.

Lantus should not be diluted or mixed with another insulin or solution. Do not change your insulin dose without consulting your healthcare professional.

8. How Lantus SoloStar Works

Lantus contains insulin glargine, a long-acting insulin analogue. It helps replace or supplement insulin when the body does not produce enough insulin or requires additional insulin for blood glucose management.

After subcutaneous administration, insulin glargine provides prolonged insulin activity, helping glucose move from the bloodstream into tissues and helping reduce excessive blood glucose levels. This provides basal insulin coverage that can work throughout the day and night.

9. Safety Advice for Lantus SoloStar

  • Use only under the supervision of a qualified healthcare professional.

  • Do not use Lantus during an episode of low blood sugar.

  • Monitor blood glucose as recommended by your healthcare professional.

  • Do not change the dose or insulin type without medical advice.

  • Take Lantus at the prescribed time, generally at the same time each day.

  • Never share insulin pens, needles or syringes.

  • Do not reuse needles.

  • Rotate injection sites regularly.

  • Do not inject into areas that are bruised, scarred, hard, damaged, lumpy or unusually thickened.

  • Do not mix or dilute Lantus with other insulin or solutions.

  • Do not use the product if the solution is cloudy, colored or contains particles.

  • Tell your doctor if you have kidney or liver problems.

  • Inform your healthcare professional about all medicines, supplements and diabetes treatments you use.

  • Alcohol and some medicines may affect blood glucose and may increase the risk of hypoglycemia.

  • Be cautious with driving or operating machinery until you know how insulin affects your blood glucose.

  • Seek emergency medical assistance for symptoms of severe hypoglycemia or a serious allergic reaction.

Lantus should be stored and handled according to the product instructions and applicable cold-chain requirements.

10. FAQs

Q1. What is Lantus SoloStar 100 IU 3 mL?
Lantus SoloStar is a prefilled insulin pen containing insulin glargine 100 Units/mL, a long-acting insulin used to control high blood glucose in diabetes.

Q2. How often is Lantus generally used?
Lantus is generally administered once daily at the same time each day, but the exact dose and schedule must be determined by the prescribing healthcare professional.

Q3. Can Lantus be used for diabetic ketoacidosis?
No. Lantus is not indicated for treating diabetic ketoacidosis.

Q4. Where is Lantus SoloStar injected?
It is injected under the skin. Common injection areas include the abdomen, thighs and outer upper-arm fatty tissue. Injection sites should be rotated.

Q5. Can I share my Lantus SoloStar pen?
No. Lantus SoloStar is for single-patient use. Pens and needles should never be shared, even if the needle has been changed.

Q6. What is the most important side effect of Lantus?
Hypoglycemia, or low blood sugar, is the most common and potentially serious side effect associated with insulin therapy.

Q7. Can I change my Lantus dose myself?
No. Dose adjustments should be made only according to the instructions of your healthcare professional.

Q8. Does Lantus cause weight gain?
Weight gain can occur with insulin therapy, including Lantus.

Q9. Can Lantus be mixed with another insulin?
Lantus should not be diluted or mixed with another insulin or solution.

Q10. Is Lantus SoloStar a prescription medicine?
Yes. It is a prescription insulin product and should be used under appropriate medical supervision.

11. Substitute for Lantus SoloStar

Potential alternatives containing insulin glargine or other long-acting basal insulins may exist, but the appropriate substitute depends on the patient's diabetes type, insulin requirements, blood glucose control, other medicines and local product availability.

Examples of medicines that may be considered by a healthcare professional include:

  • Insulin glargine products

  • Other long-acting basal insulin preparations

  • Other insulin regimens selected according to individual patient requirements

Do not substitute or switch insulin products without medical supervision, because different insulin products can have different strengths, dosing requirements and administration instructions.

12. SEO Keywords

Lantus SoloStar 100 IU 3 mL, Lantus insulin glargine exporter, insulin glargine 100 Units/mL supplier, Lantus SoloStar 3 mL exporter India, long acting insulin exporter India, diabetes insulin supplier India, Lantus pen exporter from India, insulin glargine pharmaceutical exporter, Lantus SoloStar wholesale supplier, diabetes medicine exporter India, insulin pen supplier India, Lantus 100 Units/mL supplier, insulin glargine exporter to USA, Lantus exporter to UK, insulin supplier to Australia, diabetes medicine exporter to Canada, Lantus supplier Singapore, insulin glargine exporter South Korea, pharmaceutical exporter to UAE, Indian pharma exporter, Nagpur medicine exporter, Lantus SoloStar global supplier, genuine insulin glargine supplier, long acting insulin supplier, diabetes care medicine exporter, prefilled insulin pen exporter, insulin glargine wholesale exporter, pharmaceutical medicine supplier India, Lantus injection supplier, global diabetes medicine exporter, insulin medicine export from India, Lantus SoloStar international supplier, Indian pharmaceutical supply, diabetes treatment medicine exporter, Phoenix Exim medicine exporter.

Sep 10th, 2026 2:43 PM

Keywords